Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 983 results
Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Two Cancer Research UK researchers working at a lab bench.

We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach. We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach.

by Nick Jones | Analysis | 13 January 2025

13 January 2025

A concept illustration of the tumour microenvironment

A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers. A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers.

by Elisa Mitchell | News | 7 January 2025

7 January 2025

A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Science & Technology
  • Health & Medicine
  • Charity News

Getting ahead of cancer: our 2024 research highlights

The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months. The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months.

by Sadaf Shafaghmotlagh, Tim Gunn | In depth | 17 December 2024

17 December 2024

Dr Yin Cao and a colleague looking at data about cancer incidence.

Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund. Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund.

by Tim Gunn | News | 11 December 2024

11 December 2024

A cancer cell dividing.

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

by Tim Gunn | News | 6 December 2024

6 December 2024

The capsule sponge shown in pill form and sponge form. Both are black and attached to a white thread.

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

by Tim Gunn | Analysis | 28 November 2024

28 November 2024

Two Cancer Research UK researchers working at a lab bench.

We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer. We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer.

by Tim Gunn | News | 20 November 2024

20 November 2024

Two researchers chatting in the lab

The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower.  The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower. 

by Sophie Wedekind | News | 20 November 2024

20 November 2024

Healthy lungs drawn as if they were an upside-down tree.

Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more. Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more.

by Tim Gunn | News | 14 November 2024

14 November 2024